Bifogade filer
Intellego granted additional time to respond to Nasdaq
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Intellego Technologies AB has received a response to its request for an extension to submit its comments regarding Nasdaq’s notice of remark. Nasdaq has granted a one-week extension, until 12th of December 2025.
The Board of Intellego is working resolutely to restore Intellego’s eligibility for listing and to enable the resumption of trading in the Intellego share.
“We welcome the additional time we have now been given to submit our response. The Board’s highest priority is to safeguard value for Intellego’s 19,000 shareholders,” says Jacob Laurin, Acting CEO.
Nasdaq issued a notice of remark to Intellego Technologies AB on 21st November 2025. The notice states that the Nasdaq intends to refer the matter to the Disciplinary Committee and will request that the Committee decide to delist Intellego shares from the First North Growth Market.
Intellego has been given the opportunity to comment on the notice and has now been granted an extended deadline for its submission.